Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study
Top Cited Papers
- 1 March 2002
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 359 (9312) , 1085-1092
- https://doi.org/10.1016/s0140-6736(02)08150-3
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case–control study nested within the Manchester cohortBritish Journal of Cancer, 2000
- Human papillomavirus is a necessary cause of invasive cervical cancer worldwideThe Journal of Pathology, 1999
- Causes of Cervical Cancer in the Philippines: a Case-Control StudyJNCI Journal of the National Cancer Institute, 1998
- Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide PerspectiveJNCI Journal of the National Cancer Institute, 1995
- Depot-medroxyprogesterone acetate, other injectable contraceptives, and cervical neoplasiaContraception, 1994
- Analysis of cytomorphologically abnormal cervical scrapes for the presence of 27 mucosotropic human papillomavirus genotypes, using polymerase chain reactionInternational Journal of Cancer, 1994
- Persistence of Type-Specific Human Papillomavirus Infection among Cytologically Normal WomenThe Journal of Infectious Diseases, 1994
- The causal link between human papillomavirus and invasive cervical cancer: A population‐based case‐control study in colombia and spainInternational Journal of Cancer, 1992
- Risk factors for cervical cancer in Colombia and SpainInternational Journal of Cancer, 1992
- Floating absolute risk: An alternative to relative risk in survival and case‐control analysis avoiding an arbitrary reference groupStatistics in Medicine, 1991